| ORIGINAL ARTICLE |
|
| Year : 2020 | Volume
: 31
| Issue : 4 | Page : 188-193 |
|
|
Comparison of the effects of tamsulosin, silodosin, and alfuzosin on catheter-free trials after acute urinary retention due to benign prostatic hyperplasia: A prospective study
Aditya Parikh1, Vipul D Yagnik2, Rajivkumar Contractor3, Jigish Vyas4, Sushil Dawka5
1 Department of Urology, Muljibhai Patel Urological Hospital, Nadiad, Gujarat, India
2 Department of Surgical Gastroenterology, Nishtha Surgical Hospital and Research Centre, Patan, Gujarat, India
3 Superintendent Surgeon, Community Health Center, Mahlav, Anand, Gujarat, India
4 Department of Surgery, Pramukhswami Medical College, Karamsad, Gujarat, India
5 Department of Surgery, SSR Medical College, Belle Rive, Mauritius
Correspondence Address:
Rajivkumar Contractor
Superintendent Surgeon, Community Health Center, Mahlav, Anand, Gujarat - 388 450
India
 Source of Support: None, Conflict of Interest: None  | 3 |
DOI: 10.4103/UROS.UROS_11_20
|
|
|
Purpose: We compared tamsulosin, silodosin, and alfuzosin in catheter-free trials after acute urinary retention (AUR) due to benign prostatic hyperplasia (BPH). This study aims at assessing the efficacy of tamsulosin, silodosin, and alfuzosin, and the factors affecting the success of catheter-free trials. Materials and Methods: An observational, prospective, randomized study of 49 men with AUR due to BPH was performed from July 2015 to August 2017. Participants were catheterized after the assessment of prevoid urine volume. The prostate size was measured, and IPSS at presentation was calculated. The participants were divided into tamsulosin, silodosin, and alfuzosin groups and were given a catheter-free trial after administration of alpha-blockers for three doses. Descriptive analysis, independent t-test, and Chi-square test were used for data analysis. Univariate and multivariate analyses were done using STATA software version 14.2. P < 0.05 was considered to indicate statistical significance. Results: The overall success of trial without catheter (TWOC) was 62.5% (30 out of 49). There was no difference in the efficacy of tamsulosin, silodosin, and alfuzosin in catheter-free trials after AUR due to BPH. The success of TWOC was affected by median lobe enlargement, and patients with Grade 3 intravesical protrusion of prostate were less likely to have a successful TWOC. Conclusion: TWOC after administration of three doses of alpha-blockers was shown to be useful in most patients irrespective of prostate size. There was no difference in the efficacy of tamsulosin, silodosin, and alfuzosin in catheter-free trials.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
